glutathione and multiple myeloma A recent editorial describes the science behind a study of mezigdomide, which augments the degradation of the proteins Ikaros Aiolos, to treat myeloma. Panel A shows the chemical structures Glutathione Depletion and Stalwart Anticancer
Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Frontiers Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment Glutathione: Lights and Shadows in Cancer Patients PMC Alterations in Glutathione Levels and Apoptotic Regulators Are Associated with Acquisition of Arsenic Trioxide Resistance in Multiple Myeloma PLOS One
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12


